Algernon NeuroScience Appoints Globally Recognized DMT Researcher and Clinician Dr. SÃ¡ndor Nardai as Principal Investigator for Planned Phase 2a DMT Human Stroke Study

Algernon NeuroScience Appoints Globally Recognized DMT Researcher and Clinician Dr. SÃ¡ndor Nardai as Principal Investigator for Planned Phase 2a DMT Human Stroke Study

Source link

What's Hot

Empire Media Named Toronto Tribune’s Marketing Agency of the Year for 2026

Snow-covered parking garage in Ottawa partially collapses, vehicles trapped

Trudeau to meet premiers as Trump tariff uncertainty continues – National

Algernon NeuroScience Appoints Globally Recognized DMT Researcher and Clinician Dr. SÃ¡ndor Nardai as Principal Investigator for Planned Phase 2a DMT Human Stroke Study

Madrigal Announces New Two-Year Data from the Compensated MASH Cirrhosis Arm of the MAESTRO-NAFLD-1 Trial Demonstrating Potential Benefit of Rezdiffra™ (resmetirom) in Patients with Compensated MASH

SILVER ONE PROVIDES UPDATE ON METALLURGICAL TEST RESULTS USING INNOVATIVE SEPARATION AND LEACHING TECHNOLOGIES AT ITS CANDELARIA SILVER MINE, NEVADA

Leafbuyer Technologies, Inc. Announces Record Results: 20% Increase in Quarterly Revenue, 68% Increase in Gross Margins and 134% Increase in Net Income

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Integral Ad Science Holding Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action – IAS

ERCOT Board approves moving ahead to finalize CenterPoint Energy's emergency generation proposal; Company's actions will lower bills for Houston-area customers and help avoid regional energy shortfall

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Innovative Industrial Properties, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – IIPR

What's Hot

Algernon NeuroScience Appoints Globally Recognized DMT Researcher and Clinician Dr. SÃ¡ndor Nardai as Principal Investigator for Planned Phase 2a DMT Human Stroke Study

Keep Reading

Subscribe to Updates